Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irene Chamorro-Herrero und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos III, 28220 Madrid, Spain. Hauptthemen laut MEDLINE: COVID-19, Cystic Fibrosis, Pluripotent Stem Cells, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Respiratory disease is one of the leading causes of morbidity and mortality worldwide. There is no cure for most diseases, which are treated symptomatically. Hence, new strategies are required to deepen the understanding of the disease and development of therapeutic strategies. The advent of stem cell and organoid technology has enabled the development of human pluripotent stem cell lines and adequate differentiation protocols for developing both airways and lung organoids in different formats. These novel human-pluripotent-stem-cell-derived organoids have enabled relatively accurate disease modeling. Idiopathic pulmonary fibrosis is a fatal and debilitating disease that exhibits prototypical fibrotic features that may be, to some extent, extrapolated to other conditions. Thus, respiratory diseases such as cystic fibrosis, chronic obstructive pulmonary disease, or the one caused by SARS-CoV-2 may reflect some fibrotic aspects reminiscent of those present in idiopathic pulmonary fibrosis. Modeling of fibrosis of the airways and the lung is a real challenge due to the large number of epithelial cells involved and interaction with other cell types of mesenchymal origin. This review will focus on the status of respiratory disease modeling from human-pluripotent-stem-cell-derived organoids, which are being used to model several representative respiratory diseases, such as idiopathic pulmonary fibrosis, cystic fibrosis, chronic obstructive pulmonary disease, and COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos III, 28220 Madrid, Spain.
ORCID-Profile: Irene Chamorro-Herrero, Alberto Zambrano
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Chamorro-Herrero, I., & Zambrano, A. (2023). Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054413
Vancouver
Chamorro-Herrero I, Zambrano A. Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054413
BibTeX
@article{ChamorroHerrero2023,
author = {Chamorro-Herrero, Irene and Zambrano, Alberto},
title = {Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054413}
}
EUVIMED